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In order to develop a self-nanoemulsifying system, three components, olive oil, Tween 80, and Capmul, 
were used to construct a ternary phase diagram that helped to find the optimum formulation, which 
was loaded with nifedipine. The effect of sonication on drug loading was also evaluated. After that, 
measurement of the droplet size, size distribution, zeta potential, and scanning electron microscopy were 
conducted for evaluation and characterisation of the formulations. The phase diagram of four formulations 
showed nanosizes below 200 nm; however, only one was selected to be loaded with nifedipine. The 
selected formulation had the lowest droplet size of 98 nm and size distribution 0.192, and was composed 
of 48% Tween 80, 32% Capmul, and 20% olive oil. The nifedipine self-nanoemulsifying drug delivery 
system (SNEDDS) showed a significant change in the particle size (97 nm) and size distribution (0.257) 
after sonication. Its zeta potential was -32.3 mV indicating good stability. The SEM photographs of 
nifedipine showed particles with spherical shape and smooth surface. Finally, a self-nanoemulsifying 
formulation containing nifedipine, loaded in olive oil, was successfully prepared by mixing the oil with 
various types of surfactants and co-surfactants. A significant nifedipine self-nanoemulsifying system 
was developed and significantly improved accordingly. 
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INTRODUCTION
The pharmaceutical industry is currently facing 
difficulties in the development of new drugs for 
oral delivery, especially those with the poor water 
solubility frequently associated with low bioavailability. 
Furthermore, oral dosage forms must be able to offer 
the greatest degree of patient compliance, be easy to 
handle, and have a low cost per unit dose (Avdeef, 
2012). Recently, the usage of medicinal nanotechnology 
formulations has grown in the pharmaceutical industry 
(Parveen, Misra, Sahoo, 2012). They are considered as 
a solution for many problems facing the pharmaceutical 
industry during the research and development of new drug 
(Kumar, 2010). In addition, the pharmaceutical industry 
has used nanotechnology in enhancing drug formulation, 
drug stability, and drug targeting to specific disease sites 
(Nikalje, 2015). 
Maximising the therapeutic index of the drug delivery 
system and reducing its side effects has become the main 
concern for the pharmaceutical industry (Keohane et al., 
2016; Shakeel et al., 2013). Furthermore, it can improve the 
ease of administration, thus indirectly improving patient 
compliance (Cerpnjak et al., 2015). Many researchers 
have presented that a self-nanoemulsifying drug delivery 
system (SNEDDS) is one of the best methods available to 
improve the oral bioavailability of poorly soluble drugs 
(Badran et al., 2014; Balakrishnan et al., 2009; Balakumar, 
Raghavan, Abdu, 2013; Hintzen et al., 2014). A study 
conducted by Vanani, Moezi, and Heli (2017) showed a 
significant increment in the absorption of curcumin in a 
self-nanoemulsifying system, leading to an enhancement 
in its bioavailability (Vanani, Moezi, Heli, 2017). Particle 
sizes less than 200 nm are usually produced, which can 
improve the chemical and/or physical stability profile in 
addition to providing long lasting storage (Memvanga, 
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Coco, Préat, 2013; Swain, Patra, Rao, 2016). 
A SNEDDS is an anhydrous homogeneous liquid drug 
delivery system consisting of oil, surfactant, co-emulsifier 
or solubiliser, and drug. SNEDDS upon dilution with 
water under gentle stirring will self-nanoemulsify into 
oil-in-water nanoemulsion spontaneously with about 
200 nm or less in average size (Eid et al., 2014a; Kuentz, 
2012; Mohsin et al., 2016). Usually, SNEDDS can readily 
spread in the gastrointestinal tract, which is due to the 
digestive motility of the intestine and the stomach that 
provides the agitation necessary for the self-emulsification 
process (Czajkowska-Kośnik et al., 2015; Mahmoud, 
Shukr, Bendas, 2014). The selection of SNEDDS 
components depends on the solubilisation capacity and 
physicochemical and physiological properties of the 
drug (Dash et al., 2015; Eid, El-Enshasy, 2014a; Kale, 
Patravale, 2008). Therefore, hydrophobic drugs are one 
of the candidates for SNEDDS. This system helps to 
improve drug oral bioavailability by several mechanisms; 
usually it is governed by the size of nanoparticles and the 
enhancement of dissolution (Abdalla, Klein, Mäder, 2008; 
Arslan, Tirnaksiz, 2013; Kohli et al., 2010). 
N i f e d i p i n e  i s  a  l o n g -  a n d  s h o r t - a c t i n g 
1,4-dihydropyridine calcium channel blocking agent. It 
is widely used in the management of hypertension and 
in the treatment of angina pectoris (Mancia et al., 2003; 
Richard, 2005). Nifedipine is a lipophilic drug and, 
thus, has poor water solubility but is soluble in ethanol. 
Moreover, it is very sensitive to light. Its poor aqueous 
solubility is considered the major problem associated with 
formulations of nifedipine. Its solubility and pH range are 
5–6 μg/mL and 4–13, respectively; those factors may cause 
it to exhibit poor pharmacokinetic properties, and also low 
and irregular bioavailability in humans (Hecq et al., 2005).
This study was conducted to develop and optimise 
formulations containing surfactants reported to be 
bioenhancers, which can help in the development of a 
nifedipine self-nanoemulsifying drug delivery system, 
and to study the effect of sonication on the formulation 
of nifedipine SNEDDS. Studying SNEDDS can provide 
important tools for the development of a drug delivery 
system that could contribute to better pharmaceutical 
products in the future.
MATERIAL AND METHODS
Material
Nifedipine (Merck, Germany), Tween 80, Capmul 
MCM (Natural Wellbeing, Malaysia), and olive oil 
(Olitalia, Italy).
Pseudo‑ternary phase diagram study
A pseudo-ternary phase diagram was constructed 
by employing a series of formulations containing oil, 
surfactant, and co-surfactant. The mixtures of olive 
oil, Tween 80, and Capmul were weighed out with an 
analytical balance (Metler Tolledo). Then, the samples 
were put in vortex for 2 minutes in order to mix the 
components of the formulation. A sample of 250 µL 
from the formulation was self-emulsified in 50 mL of 
distilled water for visual observation and to evaluate its 
droplet size and size distribution to find the region of 
emulsification. 
After observation of the droplet size was completed, 
the emulsion region was identified in the phase diagram 
for nanoemulsion (NE) region. It was identified due 
to transparent and fine particles. Meanwhile, the 
macroemulsion (ME) region was identified and appeared 
to have more whitening and isotropic solutions that 
might involve micelles, and coarse emulsion (CE) was 
the region of visibly cloudy dispersions observable 
even by visual observation. Some of the non-emulsified 
phases are not shown in the phase diagrams since they 
are beyond the scope of the present work. The optimum 
self-nanoemulsifying formulations were selected based on 
their droplets size (below 200 nm) and size distribution 
(below 0.3) (Eid et al., 2014b); those formulations were 
loaded with nifedipine to check whether the particle size 
of the formulation reached the nanosize.
Nifedipine loading into a self‑nanoemulsifying 
system
Nifedipine (10 mg) was incorporated into the 
selected self-nanoemulsifying formulation. Nifedipine 
was loaded in the selected formulation by mixing it with 
olive oil until it dissolved completely in the oil and then 
mixing it with the surfactants (Tween 80 and Capmul) in an 
Eppendorf tube. The effect of sonication was evaluated by 
sonicating the formulation for 30 minutes in a 48 °C water 
bath to facilitate the solubilisation and vortex mixing. 
Each formulation was vortexed again for 5 minutes at 
room temperature at 25 °C. Then, the nanoemulsion 
produced was analysed using a Malvern Zetasizer Nano 
ZS (Malvern Instruments, UK) and scanning electron 
microscopy (SEM) (Gupta et al., 2016).
Visual observation
Approximately 250 µL of the formulation was 
gently agitated using a glass rod after it was introduced 
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to 50 mL of distilled water in a 100 mL beaker. The 
progress of the emulsion droplets and also the tendency 
to spontaneously emulsify were observed. When the 
mixture readily formed a fine milky emulsion with 
droplets that spread easily in water, the emulsion was 
judged as “good” and it was judged “moderate” when a 
droplet was not quickly emulsified and produced milky 
emulsion. Lastly, it was judged “bad” when there was 
no or poor emulsion with immediate coalescence of oils 
droplets, especially when gentle agitation was stopped 
(Schuh, Bruxel, Teixeira, 2014). In this study, the ease of 
emulsion formation and dispersion in terms of its ability 
to spread and mix with water were observed. The time 
taken for the emulsion to be emulsified was expressed in 
terms of emulsification time.
Particle size and zeta potential analysis
Fifty millilitres of distilled water were placed in a 
100 mL beaker, then 250 µL of an oil/surfactants mixture 
were introduced and mixed using a glass rod to induce 
gentle agitation. For the screening study and construction 
of the ternary phase diagram, the resultant emulsion was 
tested for its droplet size and size distributions using a 
Malvern Mastersizer 2000MU laser diffraction particle 
analyser. Zeta potential was also performed by using 
Malvern Zetasizer Nano ZS for the optimum formulation 
(Da Costa et al., 2014). 
Scanning electron microscopy 
SEM was used to analyse the morphology of the 
nanoemulsion particles. The formulation was prepared 
as described before and then 250 µL of the formulation 
were self-emulsified in 50 mL of distilled water in a 
100 mL beaker under gentle agitation. The sample was 
centrifuged using a Sartorius Sigma Centrifuge (Sigma 
Instrument, Germany) at 10,000 rpm for 5 minutes to 
form pellets. Then, 2% osmium tetroxide was mixed 
into the pellet for 1 hour before imaging (Majeed et al., 
2015).
Statistical analysis
For statistical analysis, the Statistical Package for 
Social Science (SPSS) version 16 and Microsoft Excel 
2010 were used to analyse the obtained results. The 
results were expressed as mean ± standard deviation (SD). 




The pseudo-ternary phase diagram was constructed 
in order to find the self-nanoemulsifying region as shown 
in Figure 1. It was observed that there were different 
area divisions in the diagram. The NE area was the area 
that gave nanoemulsion droplets that were below than 
1 µm. Meanwhile, the ME area was the area that gave 
macroemulsion droplets ranging in size from larger than 
1 µm to less than 20 µm. The CE region was the area of 
the coarse-nanoemulsion formulations.
For this study, olive oil was used to mix with Tween 
80 and Capmul MCM before loading with nifedipine 
to construct the pseudo-ternary phase diagram. More 
accurate results are usually found with a combination of 
different types of surfactants compared to the results of 
using only a single surfactant. It is critical to choose the 
surfactants with the right blend of high and low hydrophile 
lipophile balance (HLB) when developing a self-
emulsifying formula to produce a successful formulation 
of a microemulsion. Surfactants with high HLB values 
have rapid self-emulsification and excellent spreading 
properties (Pouton, 2000). On the other hand, low HLB 
value surfactants exhibit poor spreading characteristics, 
long emulsion times, and poor self-emulsifying properties. 
The formation of a self-nanoemulsifying system is critical 
because it depends on the selection of surfactant mixtures. 
Usually there is a specific HLB value for each surfactant 
and oil. The selection of the right HLB for a surfactant or 
blend of surfactants, which match the oil HLB, will lead to 
FIGURE 1 - Pseudo-ternary diagram for all the formulations. 
NE: nanoemulsion, ME: macroemulsion and CE: course 
emulsion.
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providing the lowest interface tension between the oil and 
water phases. In addition, a very stable system at a lower 
level is provided when the HLB of the oil and surfactant 
used in the preparation of a self-nanoemulsifying system 
are similar. Self-emulsifying systems are very sensitive to 
the ratio of oil/surfactant mixtures.
Selected formulations
The results of the selected formulations, which 
contain olive oil mixed with Tween 80 and Capmul MCM, 
are shown in Table I. Out of all the formulations used to 
construct the ternary phase diagram, only four formulations 
gave nanosizes below 200 nm. The formulations with sizes 
below 200 nm were selected based on the criteria of the 
nanometric scale (20–200 nm) (Constantinides, Chaubal, 
Shorr, 2008; Eid, El-Enshasy, 2014b; Gutiérrez et al., 
2008; Tadros et al., 2004).
Four formulations were found to have droplet sizes 
below 200 nm with uniformity between 0.192 and 0.446 
(Figure 2). From the currently obtained results, formulation 
3 gave the smallest droplet size of 98.0 ± 3.8 nm with 
0.192 ± 0.008 size distribution compared to other 
formulations. Therefore, formulation 3 was selected for 
further evaluations as it had the lowest droplet size and 
size distribution, which are usually attributed to the better 
surfactant and co-surfactant mixture. A smaller droplet 
size may lead to better drug absorption and bioavailability, 
while the narrow size distribution is an indication of more 
uniform emulsion with better stability (Nasr, Gardouh, 
Ghorab, 2016). 
Visual observation
The visual observation of the selected formulations 
characterised the spreadability, time of emulsification, 
and appearance of each formulation as shown in Table II. 
All of the formulations had good spreadability with 
emulsification times between 55 to 26 seconds, and a 
transparent appearance.
The proportions of oil, surfactants, and co-surfactants 
in the mixture and the chemical structure of the oil will 
determine the emulsification times. This study revealed 
that the concentrations of surfactants and co-surfactants in 
the mixture had an inverse relationship with emulsification 
time. As the proportion of surfactant and co-surfactant 
increased, the self-emulsifying process became more 
difficult. The viscosity of the formulation usually would 
increase when the surfactant content increases. Hence, 
this led to formation of an emulsion with longer time 
of emulsification. Similar findings were also stated by 
Gao et al. (1998) who confirmed that an increase in the 
emulsification time would result from an increase in the 
surfactant and co-surfactant concentrations (Gao et al., 
1998). Overall, all of the formulations had good self-
TABLE I - The selected formulations that have droplet sizes below 200 nm
Formulation Tween 80 (%) Capmul (%) Olive Oil (%) Droplet Size nm ±SD Size Distribution ±SD
1 26 54 20 182 ±5.8 0.446 ±0.016
2 32 48 20 149 ±5.5 0.327 ±0.017
3 48 32 20 98 ±3.8 0.192 ±0.008
4 64 16 20 193 ±1.5 0.385 ±0.012
TABLE II - Visual observation of the self-nanoemulsifying 
formulations
Formulation Spreadability Time (s) ± 0.5 Emulsion Appearance
A Easily Spread 55 Transparent 
B Easily Spread 50 Transparent
C Easily Spread 34 Transparent
D Easily Spread 26 Transparent
FIGURE 2 - The selected Self-nanoemulsifying formulations on 
the ternary phase diagram.
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emulsification properties with the ability to form a 
cloudy emulsion in less than 60 seconds and having good 
spreading characteristics (Craig et al., 1995).
Analysis of nifedipine self‑nanoemulsifying 
system before and after sonication
Formulation 3 was noted to be the best formulation 
based on the results of the droplet size obtained from the 
Malvern Mastersizer with the lowest droplet size at 98 nm 
and size distribution of 0.192. Therefore, it was selected 
to be loaded with nifedipine.
Formulation X represents the formulation loaded 
with nifedipine but without sonication, whereas 
formulation Y was sonicated for 20 minutes using an 
ultrasonic sonicator bath. Table III shows the results of the 
droplet size, size distribution, and zeta potential for both 
formulations X and Y.
After selecting the optimum formulation, two 
formulations were loaded with nifedipine and vortexed for 
5 minutes. Formulation Y was sonicated for 20 minutes 
while formulation X was not sonicated. The results 
showed that formulation Y presented a smaller mean 
particle size (97.0 ± 2.1 nm) compared to formulation X 
(594.0 ± 5.2 nm). Even though both of the formulations 
showed nanosize particles, formulation Y showed the 
smallest particle size, thus achieving our study objective. 
Furthermore, formulation Y showed a better size 
distribution of less than 0.3, (which was 0.257 ± 0.017) 
compared to formulation X with a size distribution of 
1.10 ± 0.12. 
In addition, the drug particles in the formulations 
had different physicochemical characteristics, one of 
which was zeta potential. The stability of the formulation 
can be influenced by the charge of the substance. Zeta 
potential is the potential between the surface of a droplet 
and the dispersing liquid. It will vary according to the 
distance of the ion from the droplet surface. In general, 
emulsions are considered to be stable with negative or 
positive zeta potential of more than 30 mV (Stolnik et al., 
1994), i.e. a stable or unstable emulsion is generally 
considered at either +30 or -30 mV. The zeta potential of 
formulation Y was lower than -30 mV, which indicates 
that the formulation has better stability compared to X. 
The current results are in accordance with Nekkanti et al. 
(2010) who prepared a solid self-microemulsifying drug 
delivery system for candesartan cilexetil and found its 
zeta potential values were below -30 mV (Nekkanti et al., 
2010). Sonication is a highly complex system involving a 
variety of concomitant physicochemical interactions that 
can result in either cluster breakdown of the drug particle 
leading to reduction of the average particle size, as well 
as other effects including particle size distribution and 
drug solubility in the oil (Pradhan et al., 2016). Therefore, 
it is concluded that sonication can be indicative of more 
effectiveness in preparing a self-nanoemulsifying drug 
delivery system.
Morphology of nifedipine particles
Nifedipine particles in formulation Y were tested 
for their morphology using SEM, as it had lower droplet 
size and size distribution with better zeta potential 
compared to X. Figure 3 shows the SEM image of the 
self-nanoemulsifying formulation that was loaded with 
the nifedipine.
SEM is a technique to study the surface topography 
of a sample and a gives a 2-D image of the particles 
(Divsalar et al., 2012). SEM is considered a critical tool to 
acquire specific information about basic structural properties 
of colloidal drug delivery systems (Czajkowska-Kośnik, 
TABLE III - Mean droplet size, size distribution, and zeta potential of formulations X and Y
Formulation Droplet Size nm ±SD Size Distribution ±SD Zeta Potential (mV) ±SD
X 594 ±5.2 1.1 ±0.12 -19.4 ±2.4
Y 97 ±2.1 0.257 ±0.017 -32.3 ±1.5
FIGURE 3 - Representative SEM photographs Nifedipine 
self-nanoemulsifying system (a) 1000_ magnification, (b) 
2500_magnification and (c) 5000_magnification.
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Szekalska, 2015). All nanoparticles showed a spherical 
shape with a smooth surface at higher magnifications. 
They had a few large particles among a large population 
of small particles. The larger particles may affect the long 
term stability of the nanoemulsion; thus, it is considered 
to be unsuitable to be used for intravenous applications 
(Klang et al., 2012). The solution to this problem is 
to increase the vortex time or increase the sonication 
time. SEM images obtained for the nifedipine self-
nanoemulsifying system are shown in Figure 3. The SEM 
photographs show that the obtained particles had a spherical 
shape and were characterised by a smooth surface.
CONCLUSION
SNEDDS might be a promising approach for 
the rapid onset and the effective absorption for oral 
administration of nifedipine, thereby increasing the 
bioavailability of the drug. A self-nanoemulsifying 
formulation containing nifedipine, loaded in olive oil, 
was successfully prepared by mixing the oil with various 
types of surfactant and co-surfactants. In general, the 
self-nanoemulsifying formulations were significantly 
improved and had better self-nanoemulsifying properties 
for long term stability when it was sonicated.
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